180 related articles for article (PubMed ID: 35843717)
1. Comorbid overweight/obesity and chronic pancreatitis exacerbate the dyslipidemia progression in type 2 diabetic patients.
Marushchak M; Kozak K; Krynytska I
Endocr Regul; 2022 Jul; 56(3):168-177. PubMed ID: 35843717
[No Abstract] [Full Text] [Related]
2. Insulin receptor substrate 1 gene variations and lipid profile characteristics in the type 2 diabetic patients with comorbid obesity and chronic pancreatitis.
Marushchak M; Hevko U; Krynytska I
Endocr Regul; 2022 Feb; 56(1):1-9. PubMed ID: 35180824
[No Abstract] [Full Text] [Related]
3. Vitamin D is negatively associated with triglyceride in overweight/obese patients with type 2 diabetes.
Gong T; Di H; Han X; Hu X; Liu C; Chen G
Endocrine; 2022 May; 76(2):304-311. PubMed ID: 35247144
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
[TBL] [Abstract][Full Text] [Related]
5. Overweight and obese youth with type 1 or type 2 diabetes share similar elevation in triglycerides during middle and late adolescence.
Ashour D; AlSubaihin A; Lim YY; Legault L
Obes Res Clin Pract; 2022; 16(2):138-143. PubMed ID: 35430167
[TBL] [Abstract][Full Text] [Related]
6. Association of Vitamin D Deficiency, Dyslipidemia, and Obesity with the Incidence of Coronary Artery Diseases in Type 2 Diabetic Saudi Patients.
Gharib AF; Askary AE; Almehmadi M; Allam HH; Elsayyad LK; Althobaiti BB; Almoudhi EA; Alwethenany SH; Zahrani RAA; Shafie A
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250846
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor substrate-1 gene polymorphism and lipid panel data in type 2 diabetic patients with comorbid obesity and/or essential hypertension.
Marushchak M; Mazur L; Krynytska I
Endocr Regul; 2023 Jan; 57(1):1-11. PubMed ID: 36753667
[No Abstract] [Full Text] [Related]
8. The pattern of dyslipidemia among Somali type 2 diabetic patients: a cross-sectional study.
Alıcı G; Genç Ö
Eur J Med Res; 2022 Nov; 27(1):253. PubMed ID: 36404351
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of dyslipidemia and normal blood lipids level in Uygur population in Kashgar area of Xinjiang Uygur Autonomous Region].
Zhang ZB; Xue ZX; Wu XJ; Wang TM; Li YH; Song XL; Chao XF; Wang G; Nazibam N; Ayxamgul B; Gulbahar E; Zhou ZY; Sun BS; Wang YZ; Wang M
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jun; 38(6):702-708. PubMed ID: 28647967
[No Abstract] [Full Text] [Related]
10. [Lipid profile comparison between pre- and post-menopausal women].
Wang N; Qin MZ; Cui J
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
[No Abstract] [Full Text] [Related]
11. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
Yang T; Liu Y; Li L; Zheng Y; Wang Y; Su J; Yang R; Luo M; Yu C
Cardiovasc Diabetol; 2022 Jun; 21(1):93. PubMed ID: 35659300
[TBL] [Abstract][Full Text] [Related]
12. Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross-sectional survey of a regional cohort.
Yadegar A; Mohammadi F; Rabizadeh S; Ayati A; Seyedi SA; Nabipoorashrafi SA; Esteghamati A; Nakhjavani M
J Clin Lab Anal; 2023 Jul; 37(13-14):e24954. PubMed ID: 37537785
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
Ali N; Samadder M; Kathak RR; Islam F
PLoS One; 2023; 18(1):e0280672. PubMed ID: 36662845
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia and its predictors among adult workers in eastern Ethiopia: An institution-based cross-sectional study.
Motuma A; Shiferaw K; Gobena T; Teji Roba K; Berhane Y; Worku A
PLoS One; 2023; 18(10):e0291665. PubMed ID: 37812638
[TBL] [Abstract][Full Text] [Related]
15. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
[TBL] [Abstract][Full Text] [Related]
16. Glycolipid metabolic status of overweight/obese adolescents aged 9- to 15-year-old and the BMI-SDS/BMI cut-off value of predicting dyslipidemiain boys, Shanghai, China: a cross-sectional study.
Gong CD; Wu QL; Chen Z; Zhang D; Zhao ZY; Peng YM
Lipids Health Dis; 2013 Aug; 12():129. PubMed ID: 23984682
[TBL] [Abstract][Full Text] [Related]
17. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
Ozder A
Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
[TBL] [Abstract][Full Text] [Related]
18. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
19. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
20. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
Li JY; Wu GM; Hou Z; Cao YM
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
